Skip to main content

Advertisement

Log in

Oral shedding of human herpesviruses in patients undergoing radiotherapy/chemotherapy treatment for head and neck squamous cell carcinoma

  • Original Article
  • Published:
Clinical Oral Investigations Aims and scope Submit manuscript

Abstract

Objective

Opportunistic infections may affect the oral mucosa of patients undergoing radio/chemotherapy through exacerbation of oral mucositis. The aim of this study is to evaluate the oral shedding of all eight human herpesviruses and its possible association with oral mucositis.

Materials and methods

In this prospective cohort study, we analyzed oral rinse samples, collected weekly, from 20 patients during radiotherapy treatment. Serologic status to HSV1 and HSV2, EBV, CMV, and VZV in three different periods was performed by ELISA assay. PCR and enzymatic digestion was performed to detect HSV1, HSV2, EBV, CMV, VZV, HHV6, HHV7, and HHV8. Oral mucositis was evaluated according to the WHO criteria.

Results

Oral shedding of EBV, HHV6, and HHV7 was observed in all weeks of radiotherapy. Considering the episodes of shedding, the highest frequency was found in patients with EBV excretion (55.0%). No virus reactivation was observed by serological analysis. EBV oral shedding frequency was significantly higher than that of other viruses and showing a positive correlation with oral mucositis grade ≥2.

Conclusions

There was a positive correlation between EBV oral shedding and oral mucositis grade ≥2, particularly after 3 weeks of radiotherapy, a period in which the severity of mucositis was statistically higher. These findings allow us to infer that the local inflammatory environment in mucositis grade ≥2 is more favorable for EBV replication.

Clinical relevance

Mucositis is a frequent and important side effect of radio/chemotherapy treatment. Understanding the possible participation of viruses in the mechanism of this condition is important to develop strategies for treatment and prevention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Johansson J, Blomquist E, Montelius A, Isacsson U, Glimelius B (2004) Potential outcomes of modalities and techniques in radiotherapy for patients with hypopharyngeal carcinoma. Radiother Oncol 72(2):129–138

    Article  PubMed  Google Scholar 

  2. Fang FM, Chien CY, Tsai WL, Chen HC, Hsu HC, Lui CC et al (2008) Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy—a longitudinal study. Int J Radiat Oncol Biol Phys 72(2):356–364. doi:10.1016/j.ijrobp.2007.12.054

    Article  PubMed  Google Scholar 

  3. Parvathaneni U, Laramore GE, Liao JJ (2012) Technical advances and pitfalls in head and neck radiotherapy. J Oncol 2012:597467. doi:10.1155/2012/597467

    Article  PubMed  PubMed Central  Google Scholar 

  4. Jensen AB, Hansen O, Jorgensen K, Bastholt L (1994) Influence of late side-effects upon daily life after radiotherapy for laryngeal and pharyngeal cancer. Acta Oncol 33(5):487–491

    Article  PubMed  Google Scholar 

  5. Andrews N, Griffiths C (2001) Dental complications of head and neck radiotherapy: part 1. Aust Dent J 46(2):88–94 Review

    Article  PubMed  Google Scholar 

  6. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M et al (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(9 Suppl):1995–2025 Review

    Article  PubMed  Google Scholar 

  7. Scully C, Epstein J, Sonis S (2004) Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: diagnosis and management of mucositis. Head Neck 26(1):77–84

    Article  PubMed  Google Scholar 

  8. Lalla RV, Sonis ST, Peterson DE (2008) Management of oral mucositis in patients with cancer. Dent Clin N Am 52(1):1–17 viii

    Article  Google Scholar 

  9. Mosel DD, Bauer RL, Lynch DP, Hwang ST (2011) Oral complications in treatment of cancer patients. Oral Dis 17(6):550–559. doi:10.1111/j.1001-0825.20011.01788.x

    Article  PubMed  Google Scholar 

  10. Chen Y-K, Hou H-A, Chow J-M, Chen Y-C, Hsueh P-R, Tien H-F (2011) The impact of oral herpes simplex virus infection and candidiasis on chemotherapy-induced oral mucositis among patients with hematological malignancies. Eur J Clin Microbiol Infect Dis 30(6):753–759. doi:10.1007/s10096-010-1148-z

    Article  PubMed  Google Scholar 

  11. Gouveia de Lima A, Villar RC, de Castro G Jr, Antequera R, Gil E, Rosalmeida MC, MHH F, IML S (2012) Oral mucositis prevention by low-laser therapy in head and neck cancer patients undergoing concurrent Chemoradiotherapy: a phase III randomized study. Int J Radiat Oncol Biol Phys 82(1):270–275. doi:10.1016/j/ijrobp.2010.10.012

    Article  Google Scholar 

  12. Van der Beek MT, Laheij AM, Raber-Durlacher JE, von dem Borne PA, Wolterbeek R, van der Blij-de Brouwer CS et al (2012) Viral loads and antiviral resistance of herpesviruses and oral ulcerations in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 47(9):1222–1228. doi:10.1038/bmt.2012.2

    Article  PubMed  Google Scholar 

  13. Moslemi D, Nokhandani AM, Otaghsaraei MT, Moghadamnia Y, Kazemi S, Moghadamnia AA (2016) Management of chemo/radiation-induced oral mucositis in patients with head and neck cancer: a review of the current literature. Radiother Oncol. doi:10.1016/j.radonc.2016.04.001

    PubMed  Google Scholar 

  14. Zanin T, Zanin F, Carvalhosa AA, Castro PHS, Pachec MT, Zanin ICJ et al (2010) Use of 660-nm diode laser in prevention and treatment of human oral mucositis induced by radiotherapy and chemotherapy. Photomed Laser Surg 28(2):233–237. doi:10.1089/pho.2008.2242

    Article  PubMed  Google Scholar 

  15. Tolentino ES, Centurion BS, Ferreira LHC, Souza AP, Damante JH, Rubira-Bullen IRF (2011) Oral adverse effects of head and neck radiotherapy: literature review and suggestion of a clinical oral care guideline for irradiated patients. J Appl Oral Sci 19(5):448–454 Review

    Article  PubMed Central  Google Scholar 

  16. Melkos AB, Massenkeil G, Arnold R, Reichart PA (2003) Dental treatment prior to stem cell transplantation and its influence on the post transplantation outcome. Clin Oral Investig 7(2):113–115

    Article  PubMed  Google Scholar 

  17. Roizman B (1993) The family Herpesviridae. In: Whitley RJ, Lopez C (eds) The human herpesviruses. Raven Press, New York, pp 1–9

    Google Scholar 

  18. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM et al (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’ s sarcoma. Science 266(5192):1865–1869

    Article  PubMed  Google Scholar 

  19. Johnson G, Nelson S, Petric M, Tellier R (2000) Comprehensive PCR-based assay for detection and species identification of human herpesviruses. J Clin Microbiol 38(9):3274–3279

    PubMed  PubMed Central  Google Scholar 

  20. Wagner EK (1994) The herpes simplex type 1 virus latency gene. In: Becker Y, Darai D (eds) Pathogenicity of human herpes viruses due to specific pathogenicity genes. Springer-Verlag, Berlin, pp 210–221

    Chapter  Google Scholar 

  21. Oakley C, Epstein JB, Sherlock CH (1997) Reactivation of oral herpes simplex virus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 84(3):272–278 Review

    Article  PubMed  Google Scholar 

  22. Sonis ST (2002) The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplasic therapy. Crit Rev Oral Biol Med 13(5):380–389

    Article  PubMed  Google Scholar 

  23. Redding SW, Luce EB, Boren MW (1990) Oral herpes simplex virus infection in patients receiving head and neck radiation. Oral Surg Oral Med Oral Pathol 69(5):578–580

    Article  PubMed  Google Scholar 

  24. Nicolatou-Galitis O, Dardoufas K, Markoulatos P, Sotiropoulou-Lontou A, Kyprianou K, Kolitsi G et al (2001) Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash. J Oral Pathol Med 30(8):471–480

    Article  PubMed  Google Scholar 

  25. Epstein JB, Gorsky M, Hancock P, Peters N, Sherlock CH (2002) The prevalence of herpes simplex virus shedding and infection in the oral cavity of seropositive patients undergoing head and neck radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94(6):712–716

    Article  PubMed  Google Scholar 

  26. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK et al (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66(3):253–262 Review

    Article  PubMed  Google Scholar 

  27. Nicolatou-Galitis O, Athanassiadou P, Kouloulias V, Sotiropoulou-Lontou A, Dardoufas K, Polychronopoulou A et al (2006) Herpes simplex virus-1 (HSV-1) infection in radiation-induced oral mucositis. Support Care Cancer 14(7):753–762

    Article  PubMed  Google Scholar 

  28. Correia AVL, Coelho MRCD, de Oliveira Mendes Cahú GG, Almeida Silva JL, da Mota Vasconcelos Brasil C, de Castro JFL (2015) Seroprevalence of HSV1-2 and correlation with aggravation of oral mucositis in patients with squamous cell carcinoma of the head and neck region submitted to antineoplasic treatment. Support Care Cancer 23(7):2105–2111. doi:10.1007/s00520-014-2558-8

    Article  PubMed  Google Scholar 

  29. Anonymous (1995) The world health organization quality of life assessment (WHOQOL): position paper from the world health organization. Soc Sci Med 41(10):1403–9

  30. Rüping MJ, Keulertz C, Vehreschild JJ, Lövenich H, Söhngen D, Wieland U, Cornely OA (2011) Association of HSV reactivation and pro-inflammatory cytokine levels with the severity of stomatitis after BEAM chemotherapy and autologous SCT. Support Care Cancer 19(8):1211–1216. doi:10.1007/s00520-010-0940-8

    Article  PubMed  Google Scholar 

  31. Carvalho RR, de Paula EF, Ramalho KM, Antunes JL, Bezinelli LM, de Magalhães MH et al (2010) Effect of laser phototherapy on recurring herpes labialis prevention: an in vivo study. Lasers Med Sci 25(3):397–402. doi:10.1007/s10103-009-0717-9

    Article  PubMed  Google Scholar 

  32. Bello-Silva MS, de Freitas PM, Aranha AC, Lage-Marques JL, Simões A, de Paula Eduardo C (2010) Low- and high-intensity lasers in the treatment of herpes simplex virus 1 infection. Photomed Laser Surg 28(1):135–139. doi:10.1089/pho.2008.2458

    Article  PubMed  Google Scholar 

  33. Eduardo Cde P, Bezinelli LM, Eduardo Fde P, da Graça Lopes RM, Ramalho KM, Bello-Silva MS et al (2012) Prevention of recurrent herpes labialis outbreaks through low-intensity laser therapy: a clinical protocol with 3-year follow-up. Lasers Med Sci 27(5):1077–1083. doi:10.1007/s10103-611-1019-6

    Article  PubMed  Google Scholar 

  34. Muñoz Sanchez PJ, Capote Femenías JL, Díaz Tejeda A, Tunér J (2012) The effect of 670-nm low laser therapy on herpes simplex type 1. Photomed Laser Surg 30(1):37–40. doi:10.1089/pho.2011.3076

    Article  PubMed  Google Scholar 

  35. de Paula Eduardo C, Aranha AC, Simões A, Bello-Silva MS, Ramalho KM, Esteves-Oliveira M et al (2014) Laser treatment of recurrent herpeslabialis: a literature review. Lasers Med Sci 29(4):1517–1529. doi:10.1007/s10103-01301311

    PubMed  Google Scholar 

  36. Dougal G, Lee SY (2003) Evaluation of the efficacy of low-level light therapy using 1072 nm infrared light for the treatment of herpes simplex labialis. Clin Exp Dermatol 38(7):713–718. doi:10.1111/ced.12069

    Google Scholar 

  37. Stona P, da Silva VE, Dos Santos Pires L, Blessmann Weber JB, Floriani Kramer P (2014) Recurrent labial herpes simplex in pediatric dentistry: low-level laser therapy as a treatment option. Int J Clin Pediatr Dent 7(2):140–143. doi:10.5005/jp-journals-10005-1252

    Article  PubMed  PubMed Central  Google Scholar 

  38. Ward K (2005) The natural history and laboratory diagnosis of human herpesviruses-6 and -7 infections in the immunocompetent. J Clin Virol 32(3):183–193 Review

    Article  PubMed  Google Scholar 

  39. Biganzoli P, Ferreyra L, Sicilia P, Carabajal C, Frattari S, Littvik A et al (2010) IgG subclasses and DNA detection of HHV-6 and HHV-7 in healthy individuals. J Med Virol 82(10):1679–1683. doi:10.1002/jmv.21.880

    Article  PubMed  Google Scholar 

  40. Magalhães IM, Martins R, Cossatis JJ, Cavaliere RM, Afonso LA, Moyses N et al (2010) Detection of human herpesvirus 6 and 7 DNA in saliva from healthy adults from Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 105(7):925–927

    Article  PubMed  Google Scholar 

  41. Pinheiro RS, Ferreira DC, Nobrega F, Santos NS, Souza IP, Castro GF (2013) Current status of herpesvirus identification in the oral cavity of HIV-infected children. Rev Soc Bras Med Trop 46(1):15–19

    Article  Google Scholar 

  42. Yamamoto Y, Morooka M, Hashimoto S, Ihra M, Yoshikawa T (2014) Analysis of the shedding of three β-herpesviruses in urine and saliva of children with renal disease. J Med Virol 86(3):505–511. doi:10.1002/jmv.23782

    Article  PubMed  Google Scholar 

  43. Ambinder RF, Wingard JR, Burns WH, Hayward SD, Saral R, Perry HR et al (1985) Detection of Epstein-Barr virus DNA in mouthwashes by hybridization. J Clin Microbiol 21(3):353–356

    PubMed  PubMed Central  Google Scholar 

  44. Braz-Silva PH, Ortega KL, Rezende NP, Nunes FD, Magalhães MH (2006) Detection of Epstein-Barr virus (EBV) in the oral mucosa of renal transplant patients. Diagn Cytopathol 34(1):24–28

    Article  PubMed  Google Scholar 

  45. Tsao SW, Tsang CM, Pang PS, Zhang G, Chen H, Lo KW (2012) The biology of EBV infection in human epithelial cells. Semin Cancer Biol 22(2):137–143 Review

    Article  PubMed  Google Scholar 

  46. Seoudi N, Bergmeier LA, Hagi-Pavli E, Bibby D, Fortune F (2015) The seroprevalence and salivary shedding of herpesviruses in Behçet’s syndrome and recurrent aphthous stomatitis. J Oral Microbiol 5(7):27156. doi:10.3402/jan.v7.27156.eCollection

    Article  Google Scholar 

  47. Mohammed FF, Poon I, Zhang L, Elliott L, Hodson ID, Sagar SM et al (2012) Acute-phase response reactants as objective bio- markers of radiation-induced mucositis in head and neck cancer. Head Neck 34(7):985–993. doi:10.1002/hen.21848

    Article  PubMed  Google Scholar 

  48. Krause CE, Otieno BA, Bishop GW, Phadke G, Choquette L, Lalla RV et al (2015) Ultrasensitive microfluidic array for serum pro-inflammatory cytokines and C-reactive protein to assess oral mucositis risk in cancer patients. Anal Bioanal Chem 407(23):7239–7243. doi:10.1007/s00216-015-8873-1

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors would like to thank financial support from Conselho Nacional de Desenvolvimento Tecnológico (CNPq; grant no. 443004/2014-5 and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; grants no. 2012/04303-5 and no. 2015/03906-6.)

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paulo Henrique Braz-Silva.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Palmieri, M., Martins, V.A.d.O., Sumita, L.M. et al. Oral shedding of human herpesviruses in patients undergoing radiotherapy/chemotherapy treatment for head and neck squamous cell carcinoma. Clin Oral Invest 21, 2291–2301 (2017). https://doi.org/10.1007/s00784-016-2022-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00784-016-2022-x

Keywords

Navigation